Eradication of Malignant Carcinoma in the Breast Tissue

The Eradication of Malignant Carcinoma in the Breast Tissue Using an ATP (Adenosine-5'-Triphosphate) Inhibitor

Status

Completed

Phases

Phase 2Phase 3

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT02286778

Enrollment

Registered

2014-11-10

Start date

2016-02-29

Completion date

2017-08-01

Last updated

2017-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Cancer

Brief summary

The purpose of this study is to confirm the findings of an early study and expand our knowledge of treating Malignant Carcinoma in the Breast Tissue Using an ATP (Adenosine-5'-Triphosphate) Inhibitor.

Interventions

DIETARY_SUPPLEMENTPlacebo

DIETARY_SUPPLEMENTAcetogenins

Acetogenins BID for 12 months

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Masking

TRIPLE (Subject, Caregiver, Investigator)

Eligibility

Sex/Gender

FEMALE

Age

35 Years to 75 Years

Healthy volunteers

Inclusion criteria

* Clinical diagnosis of breast cancer * Referred to the study by their treating physician

Exclusion criteria

* Any type of treatment for breast cancer before starting the study

Design outcomes

Primary

Measure	Time frame	Description
Number of participants tumor free	12 months	assessed by MRI

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026